The 20 Best Glomus Tympanum Tumor Doctors Near Me in Ann Arbor, MI

Dr. Else’s primary appointment is with the Division of Metabolism, Endocrinology and Diabetes. He received his MD degree from the University of Hamburg, Germany. He pursued his clinical training at the University of Hamburg (Residency: Internal Medicine) and the University of Michigan (Residency: Internal Medicine, Fellowship: Endocrinology). His main research interests are the genetics of endocrine tumors. Dr. Else’s clinical practice focuses on the care for patients with benign and malignant endocrine tumors, particularly pheochromocytoma, adrenocortical tumors and neuroendocrine tumors as well as accompanying hormone excess syndromes (e.g Cushing syndrome, primary aldosteronism). Dr. Else has a particular interest in taking care of patients with hereditary syndromes that predispose to the development of endocrine tumors (e.g. Multiple Endocrine Neoplasia (MEN) type 1, MEN2A & MEN2B, Hereditary Paraganglioma Syndrome). He attends the Multidisciplinary Endocrine Oncology Clinic, where patients with tumors receive diagnostic procedures and treatment. In addition he is part of the Cancer Genetics Clinic, which evaluates patients for hereditary syndromes and also facilitates regular exams and surveillance for patients at risk for endocrine tumors. Dr. Else is rated as a Distinguished provider by MediFind in the treatment of Glomus Tympanum Tumor. He is also highly rated in 105 other conditions, according to our data. His clinical expertise encompasses Adrenal Cancer, Adrenocortical Carcinoma, Adrenal Gland Adenoma, Neuroendocrine Tumor, and Thyroidectomy. Dr. Else is board certified in Internal Medicine and Endocrinology, Diabetes & Metabolism.

Dr. Emily Stucken is an associate professor in the Department of Otolaryngology-Head and Neck Surgery at the University of Michigan. She specializes in diseases of the ear and skull base. Dr. Stucken completed a residency in Otolaryngology-Head and Neck Surgery at New York Presbyterian Hospital, the University Hospital of Columbia and Cornell. During this time, she also performed skull base operations at Memorial Sloan Kettering Cancer Center and trained in pediatric otolaryngology at the Children’s Hospital of New York. Dr. Stucken completed advanced fellowship training in otology and neurotology at the Michigan Ear Institute. Dr. Stucken has received awards for excellence in clinical care, teaching, and research. She has published numerous scholarly articles and book chapters in peer-reviewed journals and otolaryngology texts. She is an active member of the American Academy of Otolaryngology–Head and Neck Surgery and the American Neurotology Society and serves on national committees for these organizations. Dr. Stucken is also involved in humanitarian outreach work and has traveled to Cambodia to perform ear surgery on underserved patients. She is proficient in Spanish and French.Dr. Stucken is the director of the Cochlear Implant Center at the University of Michigan. In addition to her clinical practice, Dr. Stucken is invested in the advancement of knowledge and is an NIH-funded researcher in hearing sciences. She is a clinical faculty member at the Kresge Hearing Research Institute and has led international research collaboration. Dr. Stucken also runs the Temporal Bone Dissection Lab at the University of Michigan and directs the Temporal Bone Dissection Course.Dr. Stucken’s approach to otolaryngology and otology-neurotology combines a strong background of clinical and academic expertise with a dedicated personal approach to patient care. Through this personal approach, she works to help patients understand their disease process and treatment options. The ear represents one of the most complex and intricate organs in the human body; just as diseases of the ear and skull base can be debilitating to a person’s interactions with the everyday world, the treatment for these diseases can restore a patient’s quality of life. Dr. Stucken works diligently toward providing specialized care to every patient on an individual basis to achieve the best possible outcomes. Dr. Stucken is rated as a Distinguished provider by MediFind in the treatment of Glomus Tympanum Tumor. She is also highly rated in 26 other conditions, according to our data. Her clinical expertise encompasses Acoustic Neuroma, Schwannoma, Glomus Tympanum Tumor, Glomus Jugulare Tumor, and Myringotomy. Dr. Stucken is board certified in Otolaryngology-Head & Neck Surgery and Neurotology.

Hussam El is an Otolaryngologist practicing medicine in Ann Arbor, Michigan. Dr. El is rated as a Distinguished provider by MediFind in the treatment of Glomus Tympanum Tumor. He is also highly rated in 26 other conditions, according to our data. His clinical expertise encompasses Glomus Tympanum Tumor, Glomus Jugulare Tumor, Infant Hearing Loss, and DFNB1. Dr. El is board certified in Otolaryngology-Head & Neck Surgery.

Kelly Malloy is an Otolaryngologist and a Plastic Surgeon practicing medicine in Ann Arbor, Michigan. Dr. Malloy is rated as an Advanced provider by MediFind in the treatment of Glomus Tympanum Tumor. She is also highly rated in 15 other conditions, according to our data. Her clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Tongue Cancer, Laryngectomy, and Osteotomy.

Dr. Wahl is a physician scientist at the University of Michigan specializing in cancers of the central nervous system. His research focuses on the development of new treatment strategies for brain tumors and his laboratory group is especially interested in interactions between radiation and abnormal metabolism in glioblastoma. In the clinic, he cares for a wide variety of patients with both malignant and benign tumors of the central nervous system. Dr. Wahl is rated as an Advanced provider by MediFind in the treatment of Glomus Tympanum Tumor. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor.

Christopher Welch is an Otolaryngologist practicing medicine in Ann Arbor, Michigan. Dr. Welch is rated as an Advanced provider by MediFind in the treatment of Glomus Tympanum Tumor. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Acoustic Neuroma, Cholesteatoma, Schwannoma, and Infant Hearing Loss. Dr. Welch is board certified in Otolaryngology-Head & Neck Surgery and Neurotology.

Keith Casper is an Otolaryngologist practicing medicine in Ann Arbor, Michigan. Dr. Casper is rated as an Advanced provider by MediFind in the treatment of Glomus Tympanum Tumor. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Tongue Cancer, Laryngectomy, and Glossectomy. Dr. Casper is board certified in Otolaryngology-Head & Neck Surgery.

Dr. Francis Worden received his medical degree from the Indiana University School of Medicine in 1993. Prior to attending medical school, he worked as a registered pharmacist at a large community hospital in Indianapolis. In 1997, Dr. Worden completed a combined residency in internal medicine and pediatrics at the Detroit Medical Center and finished a medical oncology/hematology fellowship at the University of Michigan. In July 2000, Dr. Worden joined the faculty at the University of Michigan Rogel Cancer Center, where he is currently working as a clinical investigator with both the multidisciplinary head and neck oncology team and the multidisciplinary lung cancer team. Dr. Worden's research interests include organ preservation in head and neck cancer and endocrine oncology. He is the Nancy Wigginton Oncology Research Professor of Thyroid Cancer. Avid competitive swimmer ; cyclist and runner. Dr. Worden is rated as an Advanced provider by MediFind in the treatment of Glomus Tympanum Tumor. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Thyroid Cancer, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Worden is board certified in Medical Oncology.

Shruti Jolly MD is an Associate Professor and Associate Chair of Community Practices in the Department of Radiation Oncology at the University of Michigan. She received her undergraduate and medical degrees at Wayne State University as a Presidential Scholar. In 2007, she completed her medical training at William Beaumont Hospital in Royal Oak, Michigan where she served as chief resident and received the RSNA Roentgen Resident Research Award. Dr. Jolly then joined the faculty at the University of Michigan Department of Radiation Oncology. Dr. Jolly directs the treatment of thoracic, gynecologic and endocrine malignancies. She also serves as the director of Brachytherapy, specializing in High Dose Rate (HDR) brachytherapy procedures. Additionally, she is the principal investigator of numerous clinical protocols designed to individualize the radiation therapy of lung and gynecologic cancer patients. Dr. Jolly has authored numerous publications in peer-reviewed journals. As Associate chair of Community Practices, she oversees the standardization and quality of care of patients receiving radiation therapy at the numerous UM Radiation Oncology community practices across the state of Michigan. In addition she also serves as a consultant for the Michigan Radiation Oncology Quality Consortium (MROQC) focused on quality improvement in patients undergoing radiation therapy for breast cancer, lung cancer and bone metastases. Dr. Jolly is rated as an Advanced provider by MediFind in the treatment of Glomus Tympanum Tumor. She is also highly rated in 27 other conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Adrenal Cancer, and Pleuropulmonary Blastoma. Dr. Jolly is board certified in Radiation Oncology.

Dr. Adina Turcu completed her Internal Medicine residency at Norwalk Hospital/Yale University, CT, where she also served a year as Chief Resident. She completed her Endocrinology fellowship at Mayo Clinic, Rochester, MN, where she was the recipient of the Randall G. Sprague Award for outstanding clinical, investigative, and academic achievement in Endocrinology.Dr. Turcu pursued a postdoctoral fellowship at the University of Michigan, prior to joining the UoM faculty team in the Division of Metabolism, Endocrinology & Diabetes. Her research work focuses on adrenal disorders, including congenital adrenal hyperplasia, Cushing’s syndrome, primary aldosteronism, and pheochromocytoma/paraganglioma. Dr. Turcu is rated as an Advanced provider by MediFind in the treatment of Glomus Tympanum Tumor. She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Hyperaldosteronism, Congenital Adrenal Hyperplasia (CAH), Adrenal Gland Adenoma, Ovarian Overproduction of Androgens, and Hormone Replacement Therapy (HRT). Dr. Turcu is board certified in Endocrinology, Diabetes & Metabolism.

Dr. Mierzwa has 8 years of clinical experience in treatment of head and neck as well as gastrointestinal cancers. Her clinical research interests have included novel chemoradiation regimens for head and neck cancers as well as pancreatic cancer. Specifically, she is currently in collaboration with the Department of Otolaryngology as part of a clinical trial to identify radiographic and serum biomarkers for oropharynx cancer patients who may be eligible for de-escalation of chemoradiation. Dr. Mierzwa is rated as an Experienced provider by MediFind in the treatment of Glomus Tympanum Tumor. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Throat Cancer, Laryngeal Cancer, Dry Mouth, and Pancreaticoduodenectomy. Dr. Mierzwa is board certified in Radiation Oncology.

David Altshuler is a Neurosurgery provider practicing medicine in Ann Arbor, Michigan. Dr. Altshuler is rated as an Experienced provider by MediFind in the treatment of Glomus Tympanum Tumor. He is also highly rated in 48 other conditions, according to our data. His clinical expertise encompasses Pituitary Tumor, Rathke Cleft Cyst, Craniopharyngioma, Awake Craniotomy, and Extracranial-Intracranial Bypass Surgery.

Michelle Kim, M.D. is an associate professor in the Department of Radiation Oncology at the University of Michigan. She completed her medical training at Case Western Reserve University and her residency at MD Anderson Cancer Center. Dr. Kim is board-certified in Radiation Oncology by the American Board of Radiology. Her research focus is in the adaptive individualization of radiation therapy using advanced molecular and functional imaging for patients with central nervous system tumors including gliomas and brain metastases. Dr. Kim is rated as an Experienced provider by MediFind in the treatment of Glomus Tympanum Tumor. She is also highly rated in 30 other conditions, according to our data. Her clinical expertise encompasses Posterior Fossa Tumor, Primitive Neuroectodermal Tumor (PNET), Metastatic Brain Tumor, and Astrocytoma. Dr. Kim is board certified in Radiation Oncology.

Dr. B. Gregory Thompson was born in Kansas City, Missouri, the oldest son in a family of eleven children. Dr. Thompson attended Harvard College, where he played football and studied English and biology. He graduated from the University of Kansas School of Medicine and subsequently entered neurosurgery residency training at the University of Pittsburgh, where he did elective rotations in neurology at Queen Square in London, England, and as a Medical Staff Research Fellow at the National Institutes of Health in Bethesda, Maryland.Following his residency in Pittsburgh, Dr. Thompson did a neurovascular and skull base surgery fellowship at the Barrow Neurological Institute and began his academic career at the University of Utah. He was then recruited to the University of Michigan.After 10 years in practice, Dr. Thompson recognized that the rapid technological and clinical development of interventional neuroradiology was a force rapidly changing cerebrovascular surgery and training, and so he returned to training as a fellow in Endovascular Neurological Surgery (ENS) at Thomas Jefferson University in Philadelphia.Upon returning full time to the University of Michigan in 2005, he became Vice Chairman of the Neurosurgery Department and established a curriculum for neurosurgery resident education in ENS. He also subsequently established a “dual training” cerebrovascular fellowship which encompasses both endovascular and advanced microsurgical techniques.Working also with a cranial base team of six otologists at Michigan, Dr Thompson has operated more than 1,000 patients with vestibular schwannomas, and their Michigan team has reported significantly improved hearing preservation results with the Middle Fossa Approach.Dr. Thompson received the University of Michigan’s Medical Student Award for Teaching Excellence in Neuroscience, the University’s Outstanding Clinician Award, and was an inaugural member of the University’s League of Clinical Excellence. He was honored with the Cerebrovascular Section’s Alfred J. Luessenhop Award in Cerebrovascular Surgery in 2011, and was appointed as a Director of the American Board of Neurological Surgery in 2012. He currently serves as the Chair of the ABNS. Dr. Thompson and his wife Ramona have 7 children and reside in Ann Arbor.50813181. Dr. Thompson is rated as an Experienced provider by MediFind in the treatment of Glomus Tympanum Tumor. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Brain Aneurysm, Subarachnoid Hemorrhage, Acoustic Neuroma, Thrombectomy, and Gastrostomy.

Dr. Mark Prince earned his medical degree at Dalhousie University Medical School in Halifax, Nova Scotia, and then served with the Canadian Armed Forces as a medical officer, receiving specialized training in hyperbaric and diving medicine. Dr. Prince returned to Dalhousie University and completed a residency in otolaryngology head and neck surgery, followed by a two-year fellowship in advanced head and neck oncology and microvascular reconstructive surgery at the University of Michigan. He joined the University of Michigan faculty in 2000, and is actively involved in resident and medical student education, serving as his department's residency program director. Dr. Prince served as the chief of the section of otolaryngology at the Ann Arbor VA Medical Center until 2009, he continues to serve there as an active staff member. His research laboratory published the first report of the identification of cancer stem cells in head and neck squamous cell cancer, and continues to conduct research in this exciting field. Dr. Prince is rated as an Experienced provider by MediFind in the treatment of Glomus Tympanum Tumor. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Throat Cancer, Acinic Cell Carcinoma of Salivary Glands, Salivary Gland Tumors, and Gastrostomy. Dr. Prince is board certified in Otolaryngology-Head & Neck Surgery.

Dr. Hogikyan is Professor and Associate Chairman of Otolaryngology-Head and Neck Surgery in the University of Michigan Medical School, and Professor of Music in the U-M School of Music, Theatre and Dance. He serves as Chief of the Division of Laryngology and General Otolaryngology (LaRGO), and Director of the University of Michigan Vocal Health Center. He is a subspecialist in Laryngology and Clinical Medical Ethics.Dr. Hogikyan received his bachelor of science degree in Cellular and Molecular Biology from the University of Michigan magna cum laude and Phi Beta Kappa in 1982. He graduated from the University of Michigan Medical School cum laude, alpha omega alpha, and with distinction in research in 1988. While in medical school he received a prestigious Howard Hughes Medical Institute-National Institutes of Health research fellowship and spent a year doing molecular genetics research at NIH. His residency in Otolaryngology-Head and Neck Surgery was at Washington University in St Louis, Missouri, and his fellowship in Laryngology was under Dr. Robert Bastian at Loyola University of Chicago. Dr. Hogikyan joined the University of Michigan faculty in 1995. He more recently undertook a fellowship in Clinical Medical Ethics at the University of Chicago MacLean Center for Clinical Medical Ethics, from where he graduated in 2019. Areas of InterestDr. Hogikyan’s clinical interests include all types of voice disorders, as well as airway and swallowing problems. He founded the University of Michigan Vocal Health Center in 1996, including a multidisciplinary clinic for occupational and professional voice users. He also serves as faculty with the Michigan Medicine Clinical Ethics Program.His laryngologic research interests include measurement of voice-related quality of life (V-RQOL), laryngeal paralysis, subglottic stenosis, and respiratory papillomatosis. His ethics-related research interests include the doctor-patient relationship, trust in the surgeon-patient relationship, and ethical considerations for patients with communication disorders.Honors and AwardsDr. Hogikyan has received numerous awards over the course of his career, with notable recent awards including:University of Michigan Medical School: Otolaryngology Teacher of the Year (2004), Dean’s Award for Community Service (2012), Resident Mentorship Award (2015, 2017), Esteemed Clinical Faculty Award (2015), LarGO Division Teaching Award (2018)American Academy of Otolaryngology-Head and Neck Surgery: Honor Award (2009), Jerome C. Goldstein Public Service Award (2018)Triological Society: Triological Thesis Honorable Mention Award for Basic Science Research (2011)American Laryngological Association: Presidential Citation (2017). Dr. Hogikyan is rated as an Experienced provider by MediFind in the treatment of Glomus Tympanum Tumor. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Spasmodic Dysphonia, Laryngectomy, and Endoscopy. Dr. Hogikyan is board certified in Otolaryngology-Head & Neck Surgery.

Dr. Lawrence structured his career to prepare to be a physician scientist by obtaining both an MD and PhD. He initially pursued internal medicine and medical oncology, but ultimately settled on radiation oncology. He is board certified in all 3 areas. He has had an active clinical practice in radiation oncology for 30 years specializing in the treatment of patients with gastrointestinal malignancies and CNS tumors.Dr. Lawrence has focused his research career in two main areas. First, in collaboration with basic scientists he developed a laboratory program in chemotherapeutic radiation sensitizers and, more recently, has studied how to integrate molecularly targeted therapies. He collaborates with basic science faculty interested in translational research to investigate new combinations that can form the basis for rational clinical trials. The second area of focus involves the use of highly conformal radiation therapy in the treatment of brain and gastrointestinal cancers. In particular, he is focusing, in collaboration with medical physicists, radiologists, imaging scientists, and biologists, on the concept of adapting treatment to the individual patient response, assessed both by state-of-the-art imaging and plasma biomarkers.Dr. Lawrence is the author of over 300 peer-reviewed publications, and his work has been continuously supported by the National Cancer Institute for over 20 years. Dr. Lawrence is rated as an Experienced provider by MediFind in the treatment of Glomus Tympanum Tumor. He is also highly rated in 24 other conditions, according to our data. His clinical expertise encompasses Glioma, Glioblastoma, Astrocytoma, Pancreaticoduodenectomy, and Tissue Biopsy. Dr. Lawrence is board certified in Radiation Oncology, Medical Oncology, and Internal Medicine.

Robbi Kupfer is an Otolaryngologist practicing medicine in Ann Arbor, Michigan. Dr. Kupfer is rated as an Experienced provider by MediFind in the treatment of Glomus Tympanum Tumor. She is also highly rated in 18 other conditions, according to our data. Her clinical expertise encompasses Recurrent Respiratory Papillomatosis, Spasmodic Dysphonia, Perichondritis, Laryngectomy, and Endoscopy. Dr. Kupfer is board certified in Otolaryngology-Head & Neck Surgery.

Aditya S. Pandey, M.D. achieved his Bachelors of Science in Biological and Engineering Sciences from the Washington University in St. Louis and Doctorate of Medicine from Case Western Reserve University School of Medicine. He then gained training in neurological surgery with sub-specialty training in microsurgical and endovascular treatment of cerebrovascular disorders under the guidance of Dr. Robert Rosenwasser at Thomas Jefferson University Hospital. Dr. Pandey specializes in treating individuals who have blood vessel related diseases of the brain and spinal cord (e.g., aneurysms, AVM, stroke, fistulas, cavernomas, bleeding within the brain, etc.) as well as practicing general neurosurgery (spinal disorders, brain tumors, and traumatic brain injury). Dr. Pandey is able to perform the latest techniques to treat stroke utilizing suction-stent thrombectomy techniques as well as treating the most complex of aneurysms utilizing flow diversion technology. He is one of two neurosurgeons in the Ann Arbor region who are trained to perform both open surgeries and endovascular procedures when treating patients with brain blood vessel related diseases. Dr. Pandey is rated as an Experienced provider by MediFind in the treatment of Glomus Tympanum Tumor. He is also highly rated in 33 other conditions, according to our data. His clinical expertise encompasses Subarachnoid Hemorrhage, Arteriovenous Malformation, Brain Aneurysm, Thrombectomy, and Stent Placement. Dr. Pandey is board certified in Neurological Surgery.

Andrew G. Shuman, MD, FACS, HEC-C is a head & neck cancer surgeon and a tenured Professor at the University of Michigan Medical School. He serves as chief of the clinical ethics service for Michigan Bioethics.He is the Assistant Dean for Veterans Affairs University of Michigan Medical School and the Associate Chief of Staff-Education at the VA Ann Arbor Health System, where he directs the educational experience for 1600 pre- and post-doctoral trainees and learners.Dr. Shuman is internationally recognized as a thought leader in ethical issues arising within the field of otolaryngology and surgical oncology. His work involves defining the conceptual dimensions of “surgical ethics,” applying his perspective as a practicing surgeon and clinical ethicist to normative and empirical bioethics research. He received extramural research funding for his work from NIH, the VA and societal grants, and has a portfolio of publications in leading journals in the fields of ethics, oncology and otolaryngology including The New England Journal of Medicine, JAMA and Nature Medicine. He has acted as PI on projects focused on cancer treatment decision-making, precision oncology and drug shortages, tailored to directly inform both the clinical practice and legal regulation of these ethically contentious and clinically complex disciplines. He was closely involved in Michigan Medicine and the VA's pandemic response, as well as at the state and national level on the ethics of scarce resource allocation including testifying in front of the United States Senate.Dr. Shuman completed fellowships in head and neck surgical oncology at Memorial Sloan-Kettering Cancer Center, and in medical ethics at Weill Medical College of Cornell University. He completed his residency in the Department of Otolaryngology-Head and Neck Surgery at the University of Michigan. He is a graduate of the University of Michigan Medical School, and also graduated from the University of Michigan's College of Literature, Science and the Arts. Dr. Shuman is rated as an Experienced provider by MediFind in the treatment of Glomus Tympanum Tumor. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Throat Cancer, Laryngeal Cancer, Tongue Cancer, Salivary Gland Tumors, and Laryngectomy. Dr. Shuman is board certified in Otolaryngology-Head & Neck Surgery.